These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32916330)

  • 1. Fluorescence-guided surgical management of medication-related osteonecrosis of the jaws.
    Tomo S; da Cruz TM; Figueira JA; Cunha JLS; Miyahara GI; Simonato LE
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():102003. PubMed ID: 32916330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
    Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study.
    Ristow O; Otto S; Geiß C; Kehl V; Berger M; Troeltzsch M; Koerdt S; Hohlweg-Majert B; Freudlsperger C; Pautke C
    Int J Oral Maxillofac Surg; 2017 Feb; 46(2):157-166. PubMed ID: 27856150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ).
    Ristow O; Otto S; Troeltzsch M; Hohlweg-Majert B; Pautke C
    J Craniomaxillofac Surg; 2015 Mar; 43(2):290-3. PubMed ID: 25541255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Differences in Autofluorescence Between Viable and Nonvital Bone: A Case Report With Histopathologic Evaluation Performed on Medication-Related Osteonecrosis of the Jaws.
    Giovannacci I; Meleti M; Corradi D; Vescovi P
    J Oral Maxillofac Surg; 2017 Jun; 75(6):1216-1222. PubMed ID: 28061356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative light-induced fluorescence-guided surgery for medication-related osteomyelitis of the jaw.
    Kim Y; Ku JK
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103867. PubMed ID: 37898261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auto-fluorescence of the bone and its use for delineation of bone necrosis.
    Ristow O; Pautke C
    Int J Oral Maxillofac Surg; 2014 Nov; 43(11):1391-3. PubMed ID: 25128260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative efficiency of fluorescence imaging by Visually Enhanced Lesion Scope (VELscope) in patients with bisphosphonate related osteonecrosis of the jaw (BRONJ).
    Assaf AT; Zrnc TA; Riecke B; Wikner J; Zustin J; Friedrich RE; Heiland M; Smeets R; Gröbe A
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e157-64. PubMed ID: 24011463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a generic violet light in the surgical management of medication-related osteonecrosis of the jaws: a technical note.
    Ballardin C; Pereira-Stabile CL; Stabile GAV
    Oral Maxillofac Surg; 2018 Dec; 22(4):477-481. PubMed ID: 30173371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Therapeutic Effectiveness Using Fluorescence-Guided Surgery for MRONJ.
    Huang H; Zhao N; Li Q; Qiao Q; Zhang J; Guo C; Guo Y
    Biomed Res Int; 2022; 2022():1650790. PubMed ID: 36164452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: Case series and long-term follow-up.
    Tartaroti NC; Marques MM; Naclério-Homem MDG; Migliorati CA; Zindel Deboni MC
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101651. PubMed ID: 31923636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.
    Yuan A; Munz A; Reinert S; Hoefert S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Feb; 129(2):133-140. PubMed ID: 31606424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-guided bone resection: A histological analysis in medication-related osteonecrosis of the jaw.
    Wehrhan F; Weber M; Neukam FW; Geppert CI; Kesting M; Preidl RHM
    J Craniomaxillofac Surg; 2019 Oct; 47(10):1600-1607. PubMed ID: 31387830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between auto-fluorescence and tetracycline-fluorescence in medication-related osteonecrosis of the jaw-a preclinical proof of concept study in the mini-pig.
    Ristow O; Nehrbass D; Zeiter S; Arens D; Moratin J; Pautke C; Hoffmann J; Freudlsperger C; Otto S
    Clin Oral Investig; 2020 Dec; 24(12):4625-4637. PubMed ID: 32444918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
    Yoshiga D; Sasaguri M; Matsuo K; Kokuryou S; Habu M; Oda M; Kodama M; Tsurushima H; Sakaguchi O; Sakurai T; Tanaka J; Morimoto Y; Yoshioka I; Tominaga K
    Osteoporos Int; 2015 Jul; 26(7):1997-2006. PubMed ID: 26037792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
    Kuroshima S; Sasaki M; Murata H; Sawase T
    Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of illicit drugs in developing medication-related osteonecrosis (MRONJ): a systematic review.
    Sacco R; Ball R; Barry E; Akintola O
    Br J Oral Maxillofac Surg; 2021 May; 59(4):398-406. PubMed ID: 33789811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study.
    Yüce MO; Adalı E; Işık G
    Clin Oral Investig; 2021 Jul; 25(7):4529-4541. PubMed ID: 33392802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of bovine lactoferrin in the post-surgical treatment of patients suffering from bisphosphonate-related osteonecrosis of the jaws: an open-label study.
    Calvani F; Cutone A; Lepanto MS; Rosa L; Valentini V; Valenti P
    Biometals; 2018 Jun; 31(3):445-455. PubMed ID: 29435826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.